BioMarin Pharmaceuticals BMRN Change in Inventories
Change in Inventories at other companies
Other financials
Where this comes from
Reported directly by BioMarin Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.
The official record: BioMarin Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioMarin Pharmaceuticals's change in inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioMarin Pharmaceuticals's change in inventories?
- BioMarin Pharmaceuticals (BMRN) reported change in inventories of -$44.49M in Q1 2026.
- How has BioMarin Pharmaceuticals's change in inventories changed year-over-year?
- BioMarin Pharmaceuticals's change in inventories decreased by 282.8% year-over-year, from $24.34M to -$44.49M.
- What is the long-term trend for BioMarin Pharmaceuticals's change in inventories?
- Over 3 years (2021 to 2025), BioMarin Pharmaceuticals's change in inventories has grown at a 49.4% compound annual growth rate (CAGR), from $35.06M to $116.93M.
- What does change in inventories mean?
- The change in the value of goods held in stock.
- How do you interpret change in inventories?
- An increase in inventory consumes cash and may signal anticipated demand or supply chain inefficiencies; a decrease releases cash.
- How does change in inventories compare across companies?
- Critical for manufacturing and pharma; peers manage this based on product shelf-life and supply chain reliability.